Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Exercise Pathophysiology in Patients with Chronic Mountain Sickness

  • Herman Groepenhoff
  • , Marieke J. Overbeek
  • , Massimiliano Mulè
  • , Mart Van Der Plas
  • , Paola Argiento
  • , Francisco C. Villafuerte
  • , Sophia Beloka
  • , Vitalie Faoro
  • , Jose L. Macarlupu
  • , Herve Guenard
  • , Claire De Bisschop
  • , Jean Benoit Martinot
  • , Rebecca Vanderpool
  • , Dante Penaloza
  • , Robert Naeije
  • VU University Medical Center
  • University of Catania
  • Onze Lieve Vrouwe Gasthuis
  • Second University of Naples
  • Free University of Brussels
  • University Hospital Bordeaux
  • Poitiers University
  • St Elisabeth Hospital
  • Universidad Peruana Cayetano Heredia

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

77 Citas (Scopus)

Resumen

Background: Chronic mountain sickness (CMS) is characterized by a combination of excessive erythrocytosis, severe hypoxemia, and pulmonary hypertension, all of which affect exercise capacity. Methods: Thirteen patients with CMS and 15 healthy highlander and 15 newcomer lowlander control subjects were investigated at an altitude of 4,350 m (Cerro de Pasco, Peru). All of them underwent measurements of diffusing capacity of lung for nitric oxide and carbon monoxide at rest, echocardiography for estimation of mean pulmonary arterial pressure and cardiac output at rest and at exercise, and an incremental cycle ergometer cardiopulmonary exercise test. Results: The patients with CMS, the healthy highlanders, and the newcomer lowlanders reached a similar maximal oxygen uptake at 32 ± 1, 32 ± 2, and 33 ± 2 mL/min/kg, respectively, mean ± SE (P = .8), with ventilatory equivalents for CO2 vs end-tidal PCO2, measured at the anaerobic threshold, of 0.9 ± 0.1, 1.2 ± 0.1, and 1.4 ± 0.1 mm Hg, respectively (P < .001); arte rial oxygen content of 26 ± 1, 21 ± 2, and 16 ± 1 mL/dL, respectively (P < .001); diffusing capacity for carbon monoxide corrected for alveolar volume of 155% ± 4%, 150% ± 5%, and 120% ± 3% predicted, respectively (P < .001), with diffusing capacity for nitric oxide and carbon monoxide ratios of 4.7 ± 0.1 at sea level decreased to 3.6 ± 0.1, 3.7 ± 0.1, and 3.9 ± 0.1, respectively (P < .05) and a maximal exercise mean pulmonary arterial pressure at 56 ± 4, 42 ± 3, and 31 ± 2 mm Hg, respectively (P < .001). Conclusions: The aerobic exercise capacity of patients with CMS is preserved in spite of severe pulmonary hypertension and relative hypoventilation, probably by a combination of increased oxygen carrying capacity of the blood and lung diffusion, the latter being predominantly due to an increased capillary blood volume.

Idioma originalInglés
Páginas (desde-hasta)877-884
Número de páginas8
PublicaciónChest
Volumen142
N.º4
DOI
EstadoPublicada - oct. 2012

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

  1. ODS 3: Salud y bienestar
    ODS 3: Salud y bienestar

Huella

Profundice en los temas de investigación de 'Exercise Pathophysiology in Patients with Chronic Mountain Sickness'. En conjunto forman una huella única.

Citar esto